NEW XELLIA GROUP A/S
Global leader in fermentation-based anti-infective pharmaceutical manufacturing and supply.
Översikt
- 37
- Anställda
- Okänt
- Omsättning
- 2013
- Grundat
Nyckelbeslutsfattare
Steen Riisgaard
Chairman of the Board
Michael Kocher
Chief Executive Officer
Julie McHugh
Board Member
Vicente Oller
Chief Financial Officer
+11 fler kontakter i Funnelfeedr
Beskrivning
Xellia Pharmaceuticals is a global leader in the development and manufacturing of fermentation-based, non-beta-lactam anti-infective medicines. With a rich legacy spanning over 120 years, the company provides essential Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs) to more...